PLUNKETT’S BIOTECH & GENETICS INDUSTRY ALMANAC 2022
Key Findings:
- Plunkett Research analyzes the major trends and technologies in the global Biotech & Genetics sectors. In addition, Plunkett profiles hundreds of the industry’s top firms.
Key Features:
- Industry trends analysis, market data and competitive intelligence
- Market forecasts and Industry Statistics
- Industry Associations and Professional Societies List
- In-Depth Profiles of hundreds of leading companies
- Industry Glossary
- Link to our 5-minute video overview of this industry
Pages: 510
Statistical Tables Provided: 16
Companies Profiled: 392
Geographic Focus: Global
A complete market research report, including forecasts and market estimates, technologies analysis and developments at innovative firms. You will gain vital insights that can help you shape your own strategy for business development, product development and investments.
- How is the industry evolving?
- How is the industry being shaped by new technologies?
- How is demand growing in emerging markets and mature economies?
- What is the size of the market now and in the future?
- What are the financial results of the leading companies?
- What are the names and titles of top executives?
- What are the top companies and what are their revenues?
Contents, Statistics, Forecasts and Analysis Include:
Major Trends Affecting the Biotech, Pharmaceuticals & Genetics Industry
- The State of the Biotechnology Industry Today
- The Coronavirus’ Effect on the Biotech, Pharmaceuticals & Genetics Industry
- A Short History of Biotechnology
- Fast Track Drugs Come to Market in the U.S. with FDA Cooperation
- Ethanol Production Soared, But U.S. Federal Subsidy Expires
- Cellulosic Ethanol Makes Slow Commercial Progress
- Major Drug Companies Acquire or Partner With Smaller Biotech Firms
- Pharmaceutical R&D Improves with Artificial Intelligence (AI)
- From Korea to India to Singapore to China, Nations Compete Fiercely in Biotech Development
- Patients’ Genetic Profiles Plummet in Price as DNA Sequencing Technologies Advance
- Gene Therapies Target Defective Genes/CRISPR Advances DNA Editing
- Vaccines & Viruses as Therapies/mRNA Shows Great Promise
- Massive R&D Investment Required for Development and Approval of New Drug/Drug Prices Soar
- Generic Drugs Have Biggest Market Share by Unit Volume, but not by Total Revenues
- Coupons and Other Marketing Schemes Obscure the Retail Prices of Drugs in the U.S., Which Are Vastly Higher than Prices Paid in Other Nations
- Biotech and Orphan Drugs Create New Revenues for Drug Firms
- Biosimilars (Generic Biotech Drugs) Receive FDA Guidelines for Accelerated Approval/Competition Will Be Fierce
- Market for CBD Is on the Rise
- Stem Cells and 3-D Printing—A New Era of Tissue Replacement Takes Shape
- Genetically Modified (GM) Seeds and Crops Planted in Dozens of Nations/Agribio R&D Investment Is High
- Genetically Modified (GM) Foods Prompt Controversy, Labeling and Legislation
- Cloning of Farm Animals/Meat and Cheese Substitutes Created in Laboratories/3-D Printed Food Appears
- Selective Plant Breeding, Mutagenesis and Gene-Editing, Including CRISPR, as Alternatives to GM Seeds
- Immunotherapy and CAR-T Create Exciting New Approach to Fighting Cancers
- Technology Discussion—Genes and DNA
- Technology Discussion—Proteins and Proteomics
- Technology Discussion—DNA Chips
- Technology Discussion—SNPs (“Snips”)
- Technology Discussion—Synthetic Biology
- Technology Discussion—Recombinant DNA
- Technology Discussion—Polymerase Chain Reaction (PCR)Biotech, Pharmaceuticals & Genetics Industry Statistics
- Biotech Industry Statistics and Market Size Overview
- The U.S. Drug Discovery & Approval Process
- S. FDA New Drug (NDA) and Biologic (BLA) Approvals, 2020
- S. Pharmaceutical R&D Spending Versus the Number of New Molecular Entity (NME) Approvals: 1994-2020
- Employment in Life & Physical Science Occupations by Business Type, U.S.: May 2020
- Federal R&D & R&D Plant Funding for Basic Research, U.S.: Fiscal Years 2020-2022
- S. Exports & Imports of Pharmaceutical Products: 2015-1st Quarter 2021
- S. Prescription Drug Expenditures, Aggregate & Per Capita Amounts, Percent Distribution: 2012-2028
- Prescription Drug Expenditures, U.S.: Selected Years, 1985-2028
- NSF Budget by Appropriation (Dollars in Millions), Fiscal Years 2020-2022
- Global Area of Biotech Crops by Country: 2019
- Domestic & Foreign Pharmaceutical Sales, PhRMA Member Companies: 1990-2020
- Domestic U.S. Biopharmaceutical R&D & R&D Abroad, PhRMA Member Companies: 1990-2020
- Domestic U.S. Biopharmaceutical R&D & R&D Abroad Breakdown, PhRMA Member Companies: 2020
Product Details
- Publisher: Plunkett Research Ltd.; August 23, 2021
- Language: English
- ISBN: 1628319267
- ISBN: 978-1628316056
- ISBN: 9781628316056
- eText ISBN: 9781628319262
Reviews
There are no reviews yet.